These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Inhalation therapy with the new antisecretory drug ambroxol (metabolite VIII of bromhexine) in otorhinolaryngology]. Hoffmann H. Arzneimittelforschung; 1978; 28(5a):931-3. PubMed ID: 581993 [No Abstract] [Full Text] [Related]
4. Possibility of interaction among antibiotics and mucolytics in children. Principi N, Zavattini G, Daniotti S. Int J Clin Pharmacol Res; 1986; 6(5):369-72. PubMed ID: 3781700 [Abstract] [Full Text] [Related]
7. Ambroxol therapy in simple chronic bronchitis: effects on subjective symptoms and ventilatory function. Ericsson CH, Juhász J, Jönsson E, Mossberg B. Eur J Respir Dis; 1986 Oct; 69(4):248-55. PubMed ID: 3545883 [Abstract] [Full Text] [Related]
8. [Use of ambroxol in the therapy of neonatal respiratory insufficiency]. Colombo ML, Dogliani P, Ulla L. Minerva Pediatr; 1988 Jun; 40(6):333-8. PubMed ID: 3185433 [No Abstract] [Full Text] [Related]
9. [Effect of Lasolvan on the course of respiratory distress syndrome in newborn infants]. Bajorek J, Czeszyńska M, Gizejowska M, Baryła-Pankiewicz E. Pediatr Pol; 1987 Jun; 62(6):382-7. PubMed ID: 3670928 [No Abstract] [Full Text] [Related]
13. Effects of bromhexine metabolite VIII (NA 872) in an animal model of the respiratory distress syndrome. Dauberschmidt R, Kuckelt W, Bender V, Hieronymi U, Mrochen H, Winsel K, Zinsmeyer J, Meyer M. Bull Eur Physiopathol Respir; 1980 Sep 15; 16(2):135-43. PubMed ID: 6783152 [No Abstract] [Full Text] [Related]
16. [Evaluation of the effects of ambroxol in the surgical preparation of patients with bronchopulmonary disorders. Administration during intermittent positive pressure ventilation]. Minuto A, Corino T, Ceccopieri M, Bardi F. Clin Ter; 1984 Dec 31; 111(6):521-30. PubMed ID: 6396029 [No Abstract] [Full Text] [Related]